Expected discontinuation symptoms of the contraceptive pill: How effective is expectation-optimizing message framing?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032645

Enrollment

120

Registered

2024-03-11

Start date

2024-03-25

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Current users of the contraceptive pill

Interventions

Group 1: Intervention group "enriched": Enrichment of information about potential discontinuation symptoms of the contraceptive pill by proven elements of expectation-optimizing framing (positive mess

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Current use of the contraceptive pill Informed consent for participation in the study fluent in German language no or correctable visual or hearing impairment

Exclusion criteria

Exclusion criteria: Not meeting inclusion criteria

Design outcomes

Primary

Measure	Time frame
Assessment of expected discontinuation symptoms of the contraceptive pill via an adaption of the Generic Assessment of Side Effects Questionnaire (GASE) Points of measurement: prior to video presentation (Baseline), directly post video presentation (T1), 24 hours post video presentation (T2), 1 week post video presentation (T3)	—

Secondary

Measure	Time frame
Assessment of the burden of potential discontinuation symptoms (4-point Likert scale) at basline, T1, T2, T3 Assessment of discontinuation intentions (VAS, adaption of the Stages of Change Measurement) at baseline, T1, T2, T3 Potential moderators (at baseline): Perceived Sensitivity to Medication (PSM) Beliefs About Medicines Questionnaire (BMQ) (State) Trait Anxiety Inventory (STAI) Sosciodemographic data (e.g., age, marital status, reason for intake)	—

Measure

Time frame

Assessment of the burden of potential discontinuation symptoms (4-point Likert scale) at basline, T1, T2, T3 Assessment of discontinuation intentions (VAS, adaption of the Stages of Change Measurement) at baseline, T1, T2, T3 Potential moderators (at baseline): Perceived Sensitivity to Medication (PSM) Beliefs About Medicines Questionnaire (BMQ) (State) Trait Anxiety Inventory (STAI) Sosciodemographic data (e.g., age, marital status, reason for intake)

—

Countries

Germany

Contacts

Public ContactPhiline Wienand

Philipps-Universität Marburg, Fachbereich Psychologie

philine.wienand@uni-marburg.de+49 6421 28 23340

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026